Latest Insider Transactions at Spero Therapeutics, Inc. (SPRO)
This section provides a real-time view of insider transactions for Spero Therapeutics, Inc. (SPRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Spero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Spero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Esther Rajavelu CFO & CBO |
SELL
Open market or private sale
|
Direct |
17,245
-4.35%
|
$17,245
$1.3 P/Share
|
|
Nov 07
2024
|
Esther Rajavelu CFO & CBO |
SELL
Open market or private sale
|
Direct |
23,351
-5.56%
|
$23,351
$1.31 P/Share
|
|
Aug 27
2024
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,213
-0.41%
|
$2,213
$1.35 P/Share
|
|
Aug 27
2024
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
5,912
-0.77%
|
$5,912
$1.35 P/Share
|
|
Aug 27
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
2,757
-0.24%
|
$2,757
$1.35 P/Share
|
|
Aug 05
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
17,641
-1.52%
|
$17,641
$1.31 P/Share
|
|
Aug 02
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
14,800
-1.26%
|
$14,800
$1.32 P/Share
|
|
May 29
2024
|
Kathleen Tregoning |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Patrick V.J.J. Vink |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Ankit Mahadevia |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+2.55%
|
-
|
|
May 29
2024
|
John C Pottage Jr |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Frank E Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Scott Thomas Jackson |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.67%
|
-
|
|
May 29
2024
|
Milind Deshpande |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+21.87%
|
-
|
|
Feb 05
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
45,093
-3.69%
|
$45,093
$1.45 P/Share
|
|
Feb 02
2024
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
63,795
-7.89%
|
$63,795
$1.37 P/Share
|
|
Feb 02
2024
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,971
-5.48%
|
$30,971
$1.36 P/Share
|
|
Feb 02
2024
|
Kamal Hamed Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,075
-3.44%
|
$28,075
$1.37 P/Share
|
|
Feb 02
2024
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,906
-5.49%
|
$30,906
$1.37 P/Share
|
|
Feb 02
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
30,901
-2.47%
|
$30,901
$1.37 P/Share
|
|
Feb 01
2024
|
Timothy Keutzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+29.79%
|
-
|
|
Feb 01
2024
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+22.7%
|
-
|
|
Feb 01
2024
|
Tamara L Joseph Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+29.88%
|
-
|
|
Feb 01
2024
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
679,501
+35.18%
|
-
|
|
Feb 01
2024
|
Esther Rajavelu CFO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
119,866
+22.21%
|
-
|
|
Nov 13
2023
|
Esther Rajavelu CFO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Oct 05
2023
|
Frank E Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
John C Pottage Jr |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
Milind Deshpande |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+27.99%
|
-
|
|
Oct 05
2023
|
Patrick V.J.J. Vink |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
Kathleen Tregoning |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
Scott Thomas Jackson |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.36%
|
-
|
|
Oct 05
2023
|
Ankit Mahadevia |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+2.41%
|
-
|
|
Sep 13
2023
|
Kamal Hamed Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,496
-6.41%
|
$39,496
$1.27 P/Share
|
|
Aug 29
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
4,163
-0.72%
|
$4,163
$1.3 P/Share
|
|
Aug 28
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
1,854
-0.32%
|
$1,854
$1.26 P/Share
|
|
Aug 28
2023
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
9,040
-1.13%
|
$9,040
$1.26 P/Share
|
|
Aug 28
2023
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,854
-0.57%
|
$1,854
$1.26 P/Share
|
|
Aug 28
2023
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,854
-0.57%
|
$1,854
$1.26 P/Share
|
|
Aug 01
2023
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
266,000
+31.5%
|
-
|
|
Jun 12
2023
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+18.52%
|
-
|
|
Feb 03
2023
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
12,286
-1.52%
|
$12,286
$1.81 P/Share
|
|
Feb 02
2023
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
9,504
-2.95%
|
$9,504
$1.83 P/Share
|
|
Feb 02
2023
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,394
-1.03%
|
$3,394
$1.86 P/Share
|
|
Feb 02
2023
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,394
-1.03%
|
$3,394
$1.86 P/Share
|
|
Feb 01
2023
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+35.85%
|
-
|
|
Feb 01
2023
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+45.23%
|
-
|
|
Feb 01
2023
|
Tamara L Joseph Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,957
+44.77%
|
-
|